Literature DB >> 11002222

Time trends of cutaneous melanoma in Queensland, Australia and Central Europe.

C Garbe1, G R McLeod, P G Buettner.   

Abstract

BACKGROUND: The objective of this study was to describe recent developments in cutaneous melanoma from the German speaking countries in Europe (Germany, Austria, and Switzerland) and from Queensland, Australia.
METHODS: All incident invasive cutaneous melanoma cases recorded between 1986 and 1996 by the Queensland Melanoma Register and by the Central Malignant Melanoma Registry of the German Dermatological Society were included in the analysis. Weighted linear trend analyses were performed to assess significant changes over the years using yearly sample sizes as weights.
RESULTS: In Central Europe, the median tumor thickness decreased from 1.2 mm in 1986 to 0.8 mm in 1996 (P < 0.001), whereas it varied insignificantly between 0.5 mm and 0.6 mm in Queensland. The percentage of patients with Clark Level II invasion increased significantly in Queensland (P < 0.001; 1996, 61.1%) and in Central Europe (P = 0.041; 1996, 24.5%). The percentage of superficial spreading melanomas rose in Central Europe (P = 0.043; 1996, 64.4%), whereas it decreased slightly in Queensland (P = 0.032; 1996, 75%). In Queensland and in Central Europe, younger people and women presented more frequently with thinner melanomas (</= 0.75 mm).
CONCLUSIONS: In both Central Europe and Queensland, trends toward thinner and less invasive melanomas were observed between 1986 and 1996, although the median tumor thickness decreased significantly only for Central European data. Men and elderly individuals should be the focus of health-promotion activities, because they tended to present on average with thicker and prognostically poorer melanomas. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 11002222     DOI: 10.1002/1097-0142(20000915)89:6<1269::aid-cncr11>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

1.  Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

Authors:  Erin X Wei; Abrar A Qureshi; Jiali Han; Tricia Y Li; Eunyoung Cho; Jennifer Y Lin; Wen-Qing Li
Journal:  J Am Acad Dermatol       Date:  2016-07-16       Impact factor: 11.527

2.  Increasing incidence of melanoma among middle-aged adults: an epidemiologic study in Olmsted County, Minnesota.

Authors:  Garrett C Lowe; Alexandra Saavedra; Kurtis B Reed; Ana I Velazquez; Roxana S Dronca; Svetomir N Markovic; Christine M Lohse; Jerry D Brewer
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

3.  Cutaneous Malignant Melanoma in Jamaica, 1958 to 2007.

Authors:  C G Liburd; T N Gibson; B Hanchard; N Waugh; D McNaughton
Journal:  West Indian Med J       Date:  2014-08-26       Impact factor: 0.171

Review 4.  A new understanding in the epidemiology of melanoma.

Authors:  Esther Erdei; Salina M Torres
Journal:  Expert Rev Anticancer Ther       Date:  2010-11       Impact factor: 4.512

Review 5.  [Value of sentinel node biopsy considering melanoma management as an example].

Authors:  C Loquai; H Riemann; S Grabbe
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

6.  Nevi, family history, and fair skin increase the risk of second primary melanoma.

Authors:  Victor Siskind; Maria Celia B Hughes; Jane M Palmer; Judith M Symmons; Joanne F Aitken; Nicholas G Martin; Nicholas K Hayward; David C Whiteman
Journal:  J Invest Dermatol       Date:  2010-10-14       Impact factor: 8.551

7.  Melanoma screening in a hungarian nuclear power plant.

Authors:  Veronika Tóth; Beáta Somlai; Zsófia Hatvani; József Szakonyi; István Gaudi; Sarolta Kárpáti
Journal:  Pathol Oncol Res       Date:  2012-12-15       Impact factor: 3.201

8.  Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.

Authors:  Haike M J van der Velden; Michelle M van Rossum; Willeke A M Blokx; Jan B M Boezeman; Marie-Jeanne P Gerritsen
Journal:  Dermatol Res Pract       Date:  2009-12-31

9.  Determinants of survival in patients with brain metastases from cutaneous melanoma.

Authors:  M Staudt; K Lasithiotakis; U Leiter; F Meier; T Eigentler; M Bamberg; M Tatagiba; P Brossart; C Garbe
Journal:  Br J Cancer       Date:  2010-04-06       Impact factor: 7.640

10.  [Sentinel lymph node excision (SLNE) and positron emission tomography in the staging of stage I-II melanoma patients].

Authors:  A Schäfer; R A Herbst; U Beiteke; S Lange-Ionescu; H Treckmann; D Löhlein; G Thiemann; B Theophil; E-W Schwarze; H-J Bartels; P J Frosch
Journal:  Hautarzt       Date:  2003-01-15       Impact factor: 0.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.